Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection
Go back to Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection| (NASDAQ: FRNM) | Delayed: 15.99 -0.32 (1.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.31 | 52 Week High | $ | |||
| Open | $16.74 | 52 Week Low | $ | |||
| Day High | $16.74 | P/E | N/A | |||
| Day Low | $15.79 | EPS | $ | |||
| Volume | 541,627 | |||||

